LV10430B - Method for preparation of pyridine-2,4-dicarbonic acid n,n'-bis(akoxyalkyl)-diamide and application thereof - Google Patents

Method for preparation of pyridine-2,4-dicarbonic acid n,n'-bis(akoxyalkyl)-diamide and application thereof Download PDF

Info

Publication number
LV10430B
LV10430B LVP-93-301A LV930301A LV10430B LV 10430 B LV10430 B LV 10430B LV 930301 A LV930301 A LV 930301A LV 10430 B LV10430 B LV 10430B
Authority
LV
Latvia
Prior art keywords
formula
pyridine
compound
conh
physiologically acceptable
Prior art date
Application number
LVP-93-301A
Other languages
English (en)
Latvian (lv)
Other versions
LV10430A (lv
Inventor
Baader Ekkehard
Bickel Martin
Genzler-Pukall Volkmar
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of LV10430A publication Critical patent/LV10430A/xx
Publication of LV10430B publication Critical patent/LV10430B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LVP-93-301A 1989-07-20 1993-05-07 Method for preparation of pyridine-2,4-dicarbonic acid n,n'-bis(akoxyalkyl)-diamide and application thereof LV10430B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3924093A DE3924093A1 (de) 1989-07-20 1989-07-20 N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung

Publications (2)

Publication Number Publication Date
LV10430A LV10430A (lv) 1995-02-20
LV10430B true LV10430B (en) 1996-02-20

Family

ID=6385494

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-301A LV10430B (en) 1989-07-20 1993-05-07 Method for preparation of pyridine-2,4-dicarbonic acid n,n'-bis(akoxyalkyl)-diamide and application thereof

Country Status (26)

Country Link
EP (1) EP0409119B1 (pt)
JP (1) JPH0776213B2 (pt)
KR (1) KR0181945B1 (pt)
AT (1) ATE104280T1 (pt)
AU (1) AU624978B2 (pt)
CA (1) CA2021529C (pt)
CY (1) CY1997A (pt)
CZ (1) CZ280129B6 (pt)
DD (1) DD300429A5 (pt)
DE (2) DE3924093A1 (pt)
DK (1) DK0409119T3 (pt)
ES (1) ES2052112T3 (pt)
FI (1) FI94630C (pt)
HU (1) HU218274B (pt)
IE (1) IE64438B1 (pt)
IL (1) IL95121A (pt)
LT (1) LT3798B (pt)
LV (1) LV10430B (pt)
NO (1) NO177187C (pt)
NZ (1) NZ234563A (pt)
PL (1) PL166307B1 (pt)
PT (1) PT94779B (pt)
RU (1) RU1836350C (pt)
SK (1) SK357690A3 (pt)
UA (1) UA19056A (pt)
ZA (1) ZA905680B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
ATE113036T1 (de) * 1988-08-04 1994-11-15 Hoechst Ag Verbessertes verfahren zur herstellung von n,n- bis(alkoxyalkyl)-pyridin -2,4- dicarbonsäurediamiden.
DE4020570A1 (de) 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
DE4030999A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
YU9492A (sh) * 1991-02-05 1995-03-27 Hoechst Ag. 2,4- i 2,5-bis-tetrazolilni piridini i postupak za njihovo dobijanje
TW199147B (pt) * 1991-03-18 1993-02-01 Hoechst Ag
EP0541042A1 (de) * 1991-11-05 1993-05-12 Hoechst Aktiengesellschaft Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
TW222585B (pt) * 1992-09-11 1994-04-21 Hoechst Ag
DOP2002000332A (es) 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3703963A1 (de) 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3826471A1 (de) 1988-08-04 1990-02-22 Hoechst Ag Verbessertes verfahren zur herstellung von n,n'-bis(alkoxyalkyl)-pyridin-2,4-dicarbonsaeurediamiden
ATE113036T1 (de) * 1988-08-04 1994-11-15 Hoechst Ag Verbessertes verfahren zur herstellung von n,n- bis(alkoxyalkyl)-pyridin -2,4- dicarbonsäurediamiden.
DE3828140A1 (de) 1988-08-19 1990-03-01 Hoechst Ag Verbessertes verfahren zur herstellung von n,n'-bis(alkoxyalkyl)-pyridin-2,4-dicarbonsaeurediamiden sowie verwendung dieser verbindungen zur herstellung oralverabreichbarer arzneimittel

Also Published As

Publication number Publication date
KR910002799A (ko) 1991-02-26
NO177187C (no) 1995-08-02
RU1836350C (ru) 1993-08-23
FI903624A0 (fi) 1990-07-18
AU5914490A (en) 1991-01-24
ES2052112T3 (es) 1994-07-01
NZ234563A (en) 1992-12-23
NO177187B (no) 1995-04-24
CA2021529C (en) 1997-12-30
HUT54653A (en) 1991-03-28
LV10430A (lv) 1995-02-20
NO903235L (no) 1991-01-21
NO903235D0 (no) 1990-07-19
LT3798B (en) 1996-03-25
CA2021529A1 (en) 1991-01-21
IL95121A0 (en) 1991-06-10
DD300429A5 (de) 1992-06-11
IL95121A (en) 1994-08-26
PL286132A1 (en) 1991-07-29
CZ357690A3 (en) 1995-06-14
HU904549D0 (en) 1990-12-28
IE64438B1 (en) 1995-08-09
CY1997A (en) 1997-09-05
UA19056A (uk) 1997-12-25
AU624978B2 (en) 1992-06-25
SK279199B6 (sk) 1998-07-08
JPH0776213B2 (ja) 1995-08-16
PT94779A (pt) 1991-03-20
SK357690A3 (en) 1998-07-08
PL166307B1 (pl) 1995-05-31
KR0181945B1 (ko) 1999-05-01
JPH0358973A (ja) 1991-03-14
LTIP1462A (en) 1995-05-25
DE3924093A1 (de) 1991-02-07
PT94779B (pt) 1997-04-30
FI94630C (fi) 1995-10-10
DE59005328D1 (de) 1994-05-19
DK0409119T3 (da) 1994-08-08
ATE104280T1 (de) 1994-04-15
IE902642A1 (en) 1991-02-27
HU218274B (en) 2000-07-28
FI94630B (fi) 1995-06-30
EP0409119B1 (de) 1994-04-13
CZ280129B6 (cs) 1995-11-15
ZA905680B (en) 1991-04-24
EP0409119A1 (de) 1991-01-23

Similar Documents

Publication Publication Date Title
EP0885204B1 (de) Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE60121431T2 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
LV10430B (en) Method for preparation of pyridine-2,4-dicarbonic acid n,n'-bis(akoxyalkyl)-diamide and application thereof
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
EP0110259B1 (de) 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
EP0179386B1 (de) 1,4-Dihydropyridin-hydroxyamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE2841126C2 (pt)
EP0281943A2 (de) Substituierte Pyridin-2,4-dicarbonsäure-Derivate, Verfahren zu ihrer Herstellung, Verwendung derselben sowie Arzneimittel auf Basis dieser Verbindungen
DD236928A5 (de) Verfahren zur herstellung neuer 1,2,4-triazolo-carbamate
US5102896A (en) 1-acyl-2-pyrrolidinones as enhancers of learning and memory
DE69923448T2 (de) 2-aminopyridine mit kondensierten ringsubstituenten als stickstoff-oxid-synthase inhibitoren
DE2305514A1 (de) Verfahren zur herstellung von lysergsaeureamiden und dihydrolysergsaeureamiden sowie lysergsaeureamide und dihydrolysergsaeureamide und ihre verwendung
DE2802023A1 (de) Neue ergotderivate, ihre herstellung und verwendung
DE2632118A1 (de) Apovincaminolester und verfahren zu deren herstellung
EP0266308A1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE3026584A1 (de) 10-halogen-14-oxon-15-hydroxy-e-homoeburnanderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH635342A5 (de) Verfahren zur herstellung von neuen octahydro-indolo(2,3-a)-chinolizinen.
US4021430A (en) Dihydroapovincaminic acid amines
DD251555A5 (de) Verfahren zur herstellung von tetraoxoverbindungen
EP0438795A1 (de) Pyridin-2,4- und 2,5-dicarbonsäuredi(nitroxyalkyl) amide, Verfahren zu deren Herstellung sowie deren Verwendung
DE1670377B2 (de) Verfahren zur herstellung von rifamycinderivaten
CH615182A5 (pt)
DD246299A5 (de) Verfahren zur herstellung n-substituierter anziridin-2-carbonsaeurederivaten
DE2518516C3 (de) 2-(3,45-Trimethoxybenzyl)-3,4-dimethylpyridin
DE2505415C3 (de) Phosphinylanthranilsäure- bzw. Aminonicotinsäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zubereitungen